Join
Live feed
·
PRReleasevia Quantisnow
Elutia Inc. logo

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

ByQuantisnow·Wall Street's wire, on your screen.
ELUT· Elutia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELUT (Elutia Inc.) and more on Quantisnow.